Asko Uri

Prof. Dr. Asko Uri

Institute of Chemistry, University of Tartu, Tartu, Estonia
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2009 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
DLDarja Lavogina
Darja Lavogina
EEErki Enkvist
Erki Enkvist
AUAsko Uri
Asko Uri

4 September 2012 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
EEErki Enkvist
Erki Enkvist
KVKaido Viht
Kaido Viht
NBNils Bischoff
Nils Bischoff
JVJürgen Vahter
Jürgen Vahter
SSSiiri Saaver
Siiri Saaver
AUAsko Uri
Asko Uri
Up-regulation of an acidophilic protein kinase, CK2, has been established in several types of cancer. This cognition has made CK2 an important target for drug development for cancer chemotherapy. The characterization of potential drug candidates, determination of the structure and clarification of the functions of CK2 could be facilitated by the application of small-molecule fluorescent probes that bind to the active site of the enzyme with high affinity and selectivity. We have used a bisubstrate approach for the development of a highly potent inhibitor of CK2. 4,5,6,7-Tetrabromo-1H-benzimidazole was conjugated with peptides containing multiple aspartate residues via different linkers. The design of the inhibitors was by crystallographic analysis of the complex of an inhibitor with the catalytic subunit of the enzyme (CK2α). The inhibitory potency of the synthesized compounds was established in a kinetic assay that used thin layer chromatography for the measurement of the rate of phosphorylation of fluorescently labelled peptide 5-TAMRA-RADDSDDDDD. The most potent inhibitor, ARC-1502 (Ki = 0.5 nM), revealed high selectivity for CK2α in a panel of 140 protein kinases. Labelling of ARC-1502 with PromoFluor-647 gave the fluorescent probe ARC-1504 that possessed subnanomolar affinity towards both CK2α and the holoenzyme. The probe was used in a fluorescence anisotropy-based binding assay to measure the concentration of CK2α and characterize non-labelled ligands binding to the active site of CK2α.

12 November 2015 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
KVKaido Viht
Kaido Viht
SSSiiri Saaver
Siiri Saaver
JVJürgen Vahter
Jürgen Vahter
EEErki Enkvist
Erki Enkvist
DLDarja Lavogina
Darja Lavogina
AUAsko Uri
Asko Uri

26 September 2017 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
HRHedi Rahnel
Hedi Rahnel
KVKaido Viht
Kaido Viht
DLDarja Lavogina
Darja Lavogina
OMOlga Mazina
Olga Mazina
THTõiv Haljasorg
Tõiv Haljasorg
AUAsko Uri
Asko Uri


24 February 2014 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
RERamesh Ekambaram
Ramesh Ekambaram
EEErki Enkvist
Erki Enkvist
GMGanesh babu MANOHARAN
Ganesh babu MANOHARAN
MUMihkel Ugandi
Mihkel Ugandi
MKMarje Kasari
Marje Kasari
AUAsko Uri
Asko Uri
Benzoselenadiazole was used as a novel scaffold for construction of microsecond scale responsive photoluminescent probes for protein kinases.